Trulieve Cannabis (TRLV) Asset Writedowns and Impairment (2021 - 2024)

Trulieve Cannabis has reported Asset Writedowns and Impairment for 4 years, with the latest figure at $477000.0 in Q3 2024.

• On a quarterly basis, Asset Writedowns and Impairment rose 139.45% year-over-year to $477000.0 in Q3 2024; TTM through Sep 2024 was $2.2 million, a 105.53% increase from a year earlier, with the FY2023 full-year figure at $2.8 million, down 23.97% from the prior year.
• Asset Writedowns and Impairment was $477000.0 for Q3 2024 at Trulieve Cannabis, down from $1.5 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $54.6 million in Q3 2022, with the low at -$72.5 million in Q4 2022.
• Average Asset Writedowns and Impairment over 4 years is $3.0 million, with a median of $1.5 million recorded in 2024.
• The largest YoY upside for Asset Writedowns and Impairment was 1092880.0% in 2022 against a maximum downside of 1450860.0% in 2022.
• Over 4 years, Asset Writedowns and Impairment stood at $5000.0 in 2021, then slumped by 1450860.0% to -$72.5 million in 2022, then surged by 96.24% to -$2.7 million in 2023, then jumped by 117.47% to $477000.0 in 2024.
• The last three Asset Writedowns and Impairment figures came in at $477000.0 (Q3 2024), $1.5 million (Q2 2024), and $3.0 million (Q1 2024), per Business Quant data.